ipamorelin sermorelin vs. Ipamorelin vs Sermorelin: Evidence &

Also, its growth hormone-stimulating properties make it unsafe for people with active cancer ,27 and its action on the pituitary gland means its unsuitable for people with a pituitary gland disorder

CJC-1295 is a long-acting GHRH analog that produces sustained elevations in growth hormone and IGF-1 levels [2] , supporting anabolic processes and fat metabolism

15 16 Sermorelin, under the brand name Geref, was FDA-approved for pediatric growth hormone deficiency but was later taken off the market for non-medical reasons

Athletes subject to anti-doping rules should treat ipamorelin accordingly and confirm current status with their governing body

Tesamorelin: FDA-approved in 2010 under the brand name Egrifta for the reduction of excess abdominal fat in HIV-associated lipodystrophy